Rallybio (RLYB) Cash from Operations (2020 - 2026)
Rallybio (RLYB) posted Cash from Operations of 7978000.0 for Q1 2026, down 70.51% sequentially from 4679000.0 in Q4 2025, and up 21.82% YoY from 6548865.03 in Q1 2025.
Rallybio (RLYB) Cash from Operations (2020 - 2026) Analysis & Trends
Rallybio has reported Cash from Operations for 7 years, with the latest figure at 7978000.0 in Q1 2026.
- Quarterly Cash from Operations rose 21.82% year-over-year to 7978000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27586000.0 (up 37.35% YoY) and the FY2025 annual result came in at 29813000.0, up 39.51% from the prior year.
- Cash from Operations slipped to 7978000.0 in Q1 2026 per RLYB's latest filing, from 4679000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 4679000.0 in Q4 2025 and troughed at 18765000.0 in Q1 2023.
- A 5-year average of 12036588.24 and a median of 13384000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 54.4% in 2022, then surged 52.56% in 2025.
- Over 5 years, Cash from Operations stood at 15264000.0 in 2022, then increased by 23.71% to 11645000.0 in 2023, then grew by 15.31% to 9862000.0 in 2024, then jumped by 52.56% to 4679000.0 in 2025, then slumped by 70.51% to 7978000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 7978000.0, 4679000.0, and 6550000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - | 45.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.92 Mn |
| Jun 30, 2026 | 45.92 Mn |
| Mar 31, 2026 | -7.98 Mn |
| Mar 31, 2026 | -7.98 Mn |
| Dec 31, 2025 | -4.68 Mn |
| Dec 31, 2025 | -4.68 Mn |
| Sep 30, 2025 | -6.55 Mn |
| Sep 30, 2025 | -6.55 Mn |
| Jun 30, 2025 | -8.38 Mn |
| Jun 30, 2025 | -8.38 Mn |
| Mar 31, 2025 | -10.21 Mn |
| Mar 31, 2025 | -10.21 Mn |
| Dec 31, 2024 | -9.86 Mn |
| Dec 31, 2024 | -9.86 Mn |
| Sep 30, 2024 | -13.55 Mn |
| Sep 30, 2024 | -13.55 Mn |
| Jun 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -10.42 Mn |
| Mar 31, 2024 | -15.46 Mn |
| Mar 31, 2024 | -15.46 Mn |